Your session is about to expire
← Back to Search
MenABCWY vaccine for Meningococcal Meningitis
Study Summary
This trial will evaluate whether a new meningitis vaccine is safe and effective in people who have previously been vaccinated against meningitis.
- Meningococcal Meningitis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 520 Patients • NCT03587207Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What other research studies have used the MenABCWY vaccine?
"There are 20 clinical trials active that involve the MenABCWY vaccine. Of these, 12 have reached Phase 3. The majority of research related to this vaccine is being conducted in Newmarket, Ontario; however, there 726 total locations running trials for MenABCWY across the world."
To whom does this opportunity to participate in this research project extend?
"This study is designed for 15 to 25-year-olds who have meningitis or meningococcal. There is space for around 1206 patients in total."
Will this experiment still be enrolling patients?
"Although this particular trial is not currently looking for patients, information from clinicaltrials.gov suggests that it was actively recruiting at some point in the past. The last update to the posting was on June 1st, 2022. There are presently 53 other trials seeking participants."
Is this research project studying individuals below the age of 55?
"This trial is specifically for patients aged 15 to 25. There are 27 other clinical trials available for minors and 31 trials open to adults 65 and older."
What has been found in terms of MenABCWY vaccine safety?
"There is a fair amount of data supporting the safety of MenABCWY vaccine--both in terms of efficacy and general safety. Consequently, we've given it a 3."
How many test subjects are in this research?
"This particular trial is not currently looking for patients. The study was first posted on January 25th, 2021 and updated June 1st, 2022. If you are seeking other studies, there are 33 trials actively searching for patients with meningitis, meningococcal and 20 studies for MenABCWY vaccine that are still recruiting participants."
What are the main goals of this medical study?
"The primary outcome of this clinical trial is the percentage of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after vaccination. Secondary outcomes include the percentages of participants with 4-fold rises in hSBA titers against each N. meningitidis serogroup B indicator strain at 1 month after vaccination, as well as the percentages of participants with hSBA titers ≥ Lower Limit of Quantitation (LLOQ) against serogroups A, C, W, and Y at day 1,"
Share this study with friends
Copy Link
Messenger